Modalis Therapeutics Corporation closed the private placement of 1st series of unsecured convertible bonds with stock acquisition rights and the 12th stock acquisition rights on November 30, 2023.
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
67 JPY | -4.29% | -9.33% | -45.16% |
1st Jan change | Capi. | |
---|---|---|
-45.16% | 15.52M | |
+7.52% | 111B | |
+11.38% | 106B | |
-12.64% | 22.24B | |
+0.44% | 21.25B | |
-4.18% | 18.97B | |
-37.85% | 18.52B | |
-8.58% | 16.81B | |
+37.41% | 12.54B | |
-23.95% | 8.09B |
- Stock Market
- Equities
- 4883 Stock
- News Modalis Therapeutics Corporation
- Modalis Therapeutics Corporation announced that it has received ¥505.320864 million in funding from Evolution Capital Management LLC